Health Care: Drugs

Ophthotech Corp (OPHT: NASDAQ)

$52.39 0.5 | 0.96%
05/22/15 - 04:00 PM ET
Company Profile
Price and Volume
Recent Price 51.89
52 Week High 58.29
52 Week Low 35.38
Avg. Daily Vol. (Mil) 0.27
Beta (3 year) 0.00
Share Related Items
Mkt Cap (Mil) 1,779.74
Shares Out (Mil) 34.30
Float (Mil) 20.67
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 24.80
Current Ratio 25.20
LT Debt/ Equity 0.00
Total Debt / Equity 0.00
Valuation Ratios
Price Earnings n.a.
Price/Sales 21.46
Price/Book 11.01
Price/Cash Flow -26.70
Per Share Data
Earnings -2.11
Sales 2.42
Book Value 4.71
Cash Flow -1.94
Business Summary
Ophthotech Corp is a biopharmaceutical company. The Company is engaged in the development of novel therapeutics to treat diseases of the back of the eye, developing therapeutics for age-related macular degeneration.
General Information
One Penn Plaza, 19th Floor
Suite 1924
New York, NY 10119
www.ophthotechinc.com
Industry : Drugs
Sector: Health Care
Employees: 72
CEO: Dr. David R. Guyer,M.D.
Short Interest
Current Month (Mil) 1.98
Previous Month (Mil) 2.15
Short Interest Ratio (Days) 8.00
Management Effectiveness
Return on Equity n.a.
Return on Assets -13.50
Return on Investments -43.30
Profitability
Gross Margin n.a.
EBIT Margin -66.50
Profit Margin -84.30

Portfolios with OPHT

Latest OPHT Headlines from TheStreet

More Financial News for OPHT

Press Releases for OPHT

See All Press Releases

Partner Headlines for OPHT

brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter